Home / Publications / Pain Research Forum / Papers of the Week / Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial data.
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial data.
Authors
Kudrow D, Dafer R, Dodick DW, Starling A, Ailani J, Dougherty C, Kalidas K, Zhang F, Jeswani R, Patel N, Khodavirdi AC
Abstract
To assess cardiovascular (CV) safety of erenumab in clinical trial patients associated with degree of CV risk.
